GNH USA
Optimising Innovator Sourcing for Bio-Similar Development

Resources

Optimising Innovator Sourcing for Bio-Similar Development

How to optimise innovator (reference) product sourcing for biosimilar development — securing the right batches, markets and documentation cost-effectively.

By

DR. PIYUSH GUPTA (MBBS, MBA)

ASSOCIATE DIRECTOR – BUSINESS DEVELOPMENT
GNH USA

IN THIS PRESENTATION
  1. Era Of Bio Therapuetics
  2. Reverse Planning
  3. Significance Of Source Markets
  4. Effects On Registration, Costs And Time To Market
  5. Key points in sourcing Bio-similar
  6. Comparator Souring Organisation – Roles and Services.
1. ERA OF BIOTHERAPUTICS
  • Conventional Medication has been used and abused by Humanity for over a century now
  • Human body has started becoming immune to conventional medication
  • Antibiotic resistance is at it’s all time high
  • The next frontier in medicines is Bio-Therapeutics Targeting of Cells at DNA and Gene level
2. REVERSE PLANNING
  • What is Reverse planning ?
  • Conventional RnD approach do not work for Bio-similars development
  • Bio-similars are expensive to develop, clinical studies are more complex and Stability even more so.
  • Top down approach of planning the full RnD process, Trials, Studies and then looking for Comparators has led to looses of Millions of Dollors in:
    • Excess stock
    • Expired Stock
    • Wrong Packs
REVERSE PLANNING
  • Reverse Planning:
    • Start by identifying your Destination Markets
    • For Example a Bio-similar to be registered in EU needs a EU sourced comparator from Innovator with EU number of the pack.
    • While a Bio-similar for registration in RoW markets will accept comparator from any markets as long as it’s from the innovator.
    • This reverse planning can SAVE millions of Dollars in sourcing by selecting the right source markets.
3. Significance of Source Markets
  • Source Markets should be chosen based on your Destination markets
  • For Example if you plan to Target RoW Markets, there’s no point in souring products from US market
  • US products with NDC numbers are at least 3 time more expensive as compared to same brand in International packs
  • US stocks are difficult to get, highly controlled, traced and the sheer cost makes the development process un-viable.
  • In contrast to this : An International pack from Europe / Eastern Europe is available at 1/3rd the cost, in Large quantities and with Pedigree Documents.
Market Intelligence
4. Effects on Registration
  • Ultimate goal of any development is to SELL the product
  • Sell – Fast and First to Market
  • Sell – At Most competitive price
  • Example : India is a Right Hand Drive Country – Is there any point launching a Left Hand Drive Car here ?
  • Similarly if your destination is RoW – there’s no point in Sourcing of US / EU stock for RnD
  • Lack of reverse planning : Only increase development cost hence the END product COST
  • Lack of product availability from US / EU markets – delays development
  • And off course you are not FAST or First to market
5.Key points in Sourcing Bio-Similars
  • Identify your Destination Markets First
  • Check availability, Pack descriptions, SPC etc… of your comparator in planning stage
  • Call for Pack photos, Pack Scans in planning stage
  • Estimate the Quantity, Frequency etc…. in advance
  • Understand availability issues for Comparators right in the beginning.
  • Tie up your source even before you start development process
6. CSO – Comparator Sourcing Organisation
  • While Development and RnD is the a focus of Manufacturers or CROs
  • Sourcing of Innovators / Comparators can be big challenge
  • An ideal CSO should be :
    • WHO GDP Certified Site
    • With validated Storage and Shipping systems
    • With Global Reach
    • Ability to source and transport products worldwide
    • Knowledgeable about Global Market place
    • In depth Experience in Sourcing, Imports and Exports
GNH USA and GNH
  • GNH India Pharmaceuticals: DGFT-recognised export house, licensed by the State FDA and DGFT to carry out imports and exports of drugs and related products, qualified person on site in the warehouse, WHO GDP certified by SGS
  • More than 15 years of industry experience
  • Over 220,000 products
GNH USA and GNH (continued)
  • Shipping and importing Globally to over 180 countries
  • Validated Storage and Shipping systems
  • Full Traceability and Pedigree for every supply
  • In Depth Market knowledge and Market intelligence
  • Complete Regulatory and compliance support until Market launch
Market Intelligence – 1 product – 2 packs ??

Other Resources

Little-known Facts about Comparator Sourcing from Emerging Markets

View & Download Little-known Facts about Comparator Sourcing from Emerging Markets

Comparators The “Check Nut” of Clinical Trials

View & Download Comparators  The “Check Nut” of Clinical Trials

Busting Myths in Comparator Sourcing

View & Download Busting Myths in Comparator Sourcing

Our Unmatched Services

Our goal is to source, distribute and deliver pharmaceutical products to everyone who needs them most, and all without any of the unforeseen delays that you simply cannot afford.

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

Dossiers and Stability Studies

Dossiers and Stability Studies

Clinical Trials Supply

Clinical Trials Supply

Pricing

Pricing

Named-Patient Supply

Named-Patient Supply

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

Validated Cold Chain Shipment

Validated Cold Chain Shipment